FOI 5069 – Documents concerning Vyvanse

This FOI request is for documents concerning section 19A approvals for Vyvanse

Downloads

FOI 5069 – Documents concerning Vyvanse

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

FOI number:
5069-2024
FOI release date:
Publication type:
Report
Audience:
General public
Description:

This request includes 2 documents:

  1. Document: Therapeutic Goods Act 1989 Approval under subsection 19A(1) – Notice of approval for the importation and supply of specified therapeutic goods
  2. Letter by Medsurge Healthcare on the Shortage of VYVANSE lisdexamfetamine dimesilate 50mg capsule bottle (AUST R: 199226), VYVANSE lisdexamfetamine dimesilate 60 mg capsules bottle (AUST R: 284021) and alternate supply arrangement under Section 19A of the Therapeutic Goods Act 1989

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.